X4 Pharma Heads to NASDAQ Via Reverse Merger with Arsanis
28 Nov 2018 //
XCONOMY
X4 Pharma to Report Clinical Biomarker Data X4P-001 at the Upcoming 2018 (AACR)
07 May 2018 //
PRESS RELEASE
X4 Pharmaceuticals Secures $27 Million in Series B Financing
16 Nov 2017 //
PRESS RELEASE

Market Place
Sourcing Support